MedTrace Logo

Hybrid Health Education Intervention Integrated Within a Mental Health Package for Adolescent Perinatal Depression

NCT06154655 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 63

Last updated 2023-12-04

No results posted yet for this study

Summary

The goal of this clinical trial is to develop a hybrid E-zine health education intervention integrated within a mental Health package for adolescent perinatal depression.

The main objective is to:

* Develop a hybrid Health Educational Intervention offering health promotion and disease prevention services on climate change to perinatal adolescents and their caregivers.
* Study the feasibility, acceptability, and usability of E-zineMH in a pilot trial among perinatal adolescents and their caregivers in comparison to a control arm that delivers face-to-face health education in routine antenatal clinics.

Participants will be expected to attend routine antenatal appointments for the duration of the study.

In addition to the face-to-face health education delivered to both groups, the intervention group will be exposed to e-magazines on climate change.

Conditions

  • Perinatal Depression

Interventions

OTHER

E-zine

Health education will be delivered through an electronic magazine

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • University of Ibadan

    lead OTHER

Principal Investigators

  • Lola Kola, PhD · College of Medicine University of Ibadan

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
21 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-01
Primary Completion
2024-04-30
Completion
2024-05-31

Countries

  • Nigeria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06154655 on ClinicalTrials.gov